Literature DB >> 20121198

Studies of benzothiophene template as potent factor IXa (FIXa) inhibitors in thrombosis.

Shouming Wang1, Richard Beck, Toby Blench, Andrew Burd, Stuart Buxton, Maja Malic, Tenagne Ayele, Shaheda Shaikh, Suresh Chahwala, Chaman Chander, Richard Holland, Sandrine Merette, Lihua Zhao, Michael Blackney, Alexandra Watts.   

Abstract

FIXa is a serine protease enzyme involved in the intrinsic pathway of the coagulation cascade. The upstream intervention of the coagulation cascade in selectively inhibiting FIXa would leave hemostasis intact via the extrinsic pathway, leading to an optimum combination of efficacy and safety with low incidence of bleeding. We have identified 2-amindinobenzothiophene template as a lead scaffold for FIXa inhibiton based on its homology with urokinase plasminogen activator (uPA). Subsequent SAR work on the template revealed a number of highly potent FIXa inhibitors, though with moderate selectivity against FXa. X-ray study with one of the analogues demonstrated active site binding interaction with the induced opening of the S1 beta pocket and a secondary binding at the S2-S4 sites, which is in direct contrast with the previous finding.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20121198     DOI: 10.1021/jm901475e

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  1 in total

1.  Design and prediction of new anticoagulants as a selective Factor IXa inhibitor via three-dimensional quantitative structure-property relationships of amidinobenzothiophene derivatives.

Authors:  Jia-Suo Gao; Xu-Peng Tong; Yi-Qun Chang; Yu-Xuan He; Yu-Dan Mei; Pei-Hong Tan; Jia-Liang Guo; Guo-Chao Liao; Gao-Keng Xiao; Wei-Min Chen; Shu-Feng Zhou; Ping-Hua Sun
Journal:  Drug Des Devel Ther       Date:  2015-03-23       Impact factor: 4.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.